J 58 (Lamivudine and zidovudine 150 mg / 300 mg)

Pill imprint J 58 has been identified as Lamivudine and zidovudine 150 mg / 300 mg.

Lamivudine/zidovudine is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for J 58

Lamivudine and zidovudine 150 mg / 300 mg J 58 Front
Lamivudine and zidovudine 150 mg / 300 mg J 58 Back
Lamivudine and zidovudine
Imprint:
J
58
Strength:
150 mg / 300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Aurobindo Pharma Limited
National Drug Code (NDC):
65862-0597
Inactive Ingredients:
silicon dioxide
hypromellose 2910 (6 mPa.s)
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)